Skip to main content

Advertisement

SpringerLink
Log in

Does radioiodine therapy for hyperthyroidism increase long-term morbidity?

  • Practice Point
  • Published:

From Nature Clinical Practice Endocrinology & Metabolism

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Hodgson SF et al. (2003) American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 9: 544–564

    Article  Google Scholar 

  2. Bischoff-Ferrari HA et al. (2006) Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 84: 18–28

    Article  CAS  Google Scholar 

  3. Nelson HD et al. (2002) Screening for postmenopausal osteoporosis: a review of the evidence for the US Preventive Services Task Force. Ann Intern Med 137: 529–541

    Article  Google Scholar 

  4. Metso S et al. (2007) Increased cardiovascular and cancer mortality after radioiodine treatment for hyperthyroidism. J Clin Endocrinol Metab 92: 2190–2196

    Article  CAS  Google Scholar 

  5. Dobyns BM et al. (1974) Malignant and benign neoplasms of the thyroid in patients treated for hyperthyroidism: a report of the cooperative thyrotoxicosis therapy follow-up study. J Clin Endocrinol. Metab 38: 976–998

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Endocrine Section, Washington Hospital Center, 110 Irving Street, NW, Washington, DC 20010-2975, USA kenneth.d.burman@medstar.net

Authors and Affiliations

  1. Department of Medicine, KD Burman is the Chief of the Endocrine Section, Washington Hospital Center, and a Professor of Medicine, Georgetown University, Washington, DC, USA.,

    Kenneth D Burman

Authors
  1. Kenneth D Burman
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Burman, K. Does radioiodine therapy for hyperthyroidism increase long-term morbidity?. Nat Rev Endocrinol 4, 252–253 (2008). https://doi.org/10.1038/ncpendmet0780

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0780

  • Springer Nature Limited

Search

Navigation